Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07934225
PHASE3

Alpha-Lipoic Acid Added to Dapagliflozin and Insulin Resistance in Type 2 Diabetes

Sponsor: Fayoum University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to test whether adding alpha-lipoic acid (ALA) to usual treatment with metformin and dapagliflozin improves insulin resistance in adults with type 2 diabetes mellitus. The main questions it aims to answer are: * Does ALA 600 mg once daily for 12 weeks lower insulin resistance, measured by the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), more than a placebo? * Does ALA also improve blood sugar control, body weight and waist size, blood pressure, and blood fats, and is it safe and well tolerated? Participants will: * Keep taking their usual metformin and dapagliflozin 10 mg daily without any change. * Take one capsule every day for 12 weeks, either ALA 600 mg or a matching placebo (a capsule with no active ingredient), assigned by chance. * Visit the clinic at the start, at week 6, and at week 12 for blood tests, body measurements, and safety checks. Researchers will compare the ALA group with the placebo group to see if ALA lowers HOMA-IR more than placebo.

Official title: Effect of Alpha-Lipoic Acid as Add-on Therapy to Dapagliflozin on Insulin Resistance and Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Key Details

Gender

All

Age Range

30 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2026-12-01

Completion Date

2027-09-01

Last Updated

2026-11-12

Healthy Volunteers

No

Interventions

DRUG

Alpha-Lipoic Acid (ALA)

Oral capsules dispensed at study visits. Unused capsules are returned and counted at Week 6 and Week 12 to measure adherence.

DRUG

Placebo

Capsule with no active ingredient, dispensed and counted on the same schedule as the ALA capsule.

Locations (1)

Fayoum University

Al Fayyum, Egypt